Toward a Bioartificial Pancreas: Diffusion of Insulin and IgG Across Immunoprotective Membranes with Controlled Hydrophilic Channel Diameters
Research continued toward a bioartificial pancreas (BAP). Our BAPs consist of a perforated nitinol scaffold coated with reinforced amphiphilic conetwork membranes and contain live pancreatic islets. The membranes are assemblages of cocontinuous hydrophobic domains and hydrophilic channels whose diam...
Saved in:
Published in | Macromolecular bioscience Vol. 10; no. 4; pp. 369 - 377 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
08.04.2010
WILEY‐VCH Verlag Wiley-VCH |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Research continued toward a bioartificial pancreas (BAP). Our BAPs consist of a perforated nitinol scaffold coated with reinforced amphiphilic conetwork membranes and contain live pancreatic islets. The membranes are assemblages of cocontinuous hydrophobic domains and hydrophilic channels whose diameters were varied by the MW of hydrophilic segments between crosslinks (Mc,HI = 32, 44, and 74 kg · mol−1). We studied the diffusion rate of insulin, BSA, and IgG across the membrane of the BAP in the absence of islets. Membranes of Mc,HI = 74 kg · mol−1 showed rapid insulin and BSA transport and negligible IgG diffusion. BAPs containing ≈300 mouse islets showed appropriate response upon glucose challenge in vitro. The BAP implanted into diabetic mice reduced hyperglycemia and maintained islet viability for at least 4 d.
A bioartificial pancreas (BAP) was assembled by depositing nanomat‐reinforced immunoprotective amphiphilic conetwork (APCN) membranes onto a laser‐perforated nitinol scaffold and filling it with mouse islets. The figure shows mouse islets recovered from our BAP after four days of implantation into a diabetic mouse. The islets are stained and most of them are viable (viable cells are bright fluorescent green, dead cells are bright fluorescent red). |
---|---|
Bibliography: | ark:/67375/WNG-KB0Q9LTS-C The University of Akron istex:196834826E9D97E6527644820097E6BA8442EB5F ArticleID:MABI200900386 Cleveland Clinic Foundation ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1616-5187 1616-5195 |
DOI: | 10.1002/mabi.200900386 |